Change in Management
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.2 pts more than Nifty Microcap 250 and 7.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Camlin Fine Sciences reported its FY2026 audited financial results. Standalone revenue fell to Rs. 83,791.82 lakh from Rs. 88,649.13 lakh in FY2025, with standalone net loss of Rs. 1,299.66 lakh. Consolidated results showed a net loss of Rs. 3,198.61 lakh from continuing operations. Key management changes include the appointment of Mr. Pankaj Pandey as new CFO effective August 18, 2026, with current CFO Mr. Santosh Parab being re-designated as President – Strategy and Global CFO. The company also completed acquisition of Vinpai S.A. (now 83.82% owned) and saw liquidation of CFS Europe SpA in Italy. The 33rd AGM is scheduled for August 11, 2026.
The CFO transition appears to be an internal reorganization rather than a resignation, as the current CFO remains with an elevated role. The significant losses and revenue decline may concern investors, though the Vinpai acquisition and discontinued operations write-offs provide context.